BOSTON, June 18, 2025 — Maven AGI, the enterprise AI company unifying the full customer journey, today announced it has raised $50 million in Series B funding. The round was led by Dell Technologies Capital, with participation from Cisco Investments, SE Ventures (the venture capital firm backed by Schneider Electric), and existing investors Lux Capital, M13, and E14. This brings the company’s total funding to $78 million.

Several new investors are also becoming Maven customers and strategic partners, underscoring the company’s role as foundational infrastructure in the emerging AI-powered enterprise.

Originally focused on modernizing customer support, Maven AGI is now expanding across the full customer journey—connecting data, systems, and teams with agentic AI that drives business outcomes. The company’s Business AGI platform integrates seamlessly with enterprise systems to resolve issues, surface real-time insights, and improve performance at every customer touchpoint.

From the beginning, Maven has prioritized three core principles that set its platform apart for the enterprise:

• Trust – Maven prioritizes traceability, security, and compliance. The platform is fully compliant with SOC 2 Type II, HIPAA, PCI-DSS, CCPA and GDPR standards.
• Speed – With more than 100 plug-and-play integrations, Maven enables customers to launch in days and realize value quickly.
• Depth – Maven’s agentic AI is outcome-driven, capable of anticipating issues and proactively resolving them, rather than simply reacting to support requests.

“With fragmented systems slowing innovation, enterprises are urgently seeking a unified approach. Maven delivers on that need with AI that securely connects people, systems, and data across the entire customer lifecycle,” said Jonathan Corbin, CEO and co-founder of Maven AGI.

The Series B funding will fuel Maven’s continued expansion, including accelerated product development and go-to-market efforts. In a fast-moving market, the company is prioritizing rapid distribution and working closely with a network of partners and investors who have scaled some of the most successful technology companies in the world.

“Maven AGI is tackling one of the fastest-growing markets globally, and they’ve assembled a team with unmatched expertise in customer experience and AI,” said Elana Lian, Partner at Dell Technologies Capital. “Their leadership’s hands-on understanding of scaling impactful solutions positions them to fundamentally transform how businesses engage with customers.”

Maven’s momentum includes:

• 0-40 enterprise customers over the last year
• $0–$7M in revenue in 2024
• Multi-year, seven-figure enterprise deals
• 100% customer renewal rate

With a team of more than 80 employees across Boston, New York, and San Francisco, Maven serves a diverse roster of customers. These include publicly traded companies like Ibex, Tripadvisor, and SS&C Technologies Holdings, Inc.; fintech leaders such as Rho, Check, and Papaya Pay; established enterprises like Clio; and fast-rising consumer brands including Paris Hilton’s Parivie Beauty.

“Maven is built for scale. As AI becomes the operating system of the enterprise, our mission is to ensure it delivers real business impact from sales to support and everything in between,” Corbin added.

For more information or to request a demo, visit mavenagi.com.

About Maven AGI
Maven AGI builds enterprise-ready AI agents to support the full customer journey, with a focus on complex, high-friction enterprise environments. Its platform serves as a connected, intelligent operating layer that unifies systems, syncs functions, and orchestrates real-time action across the enterprise. Maven’s mission is to build Business AGI.

Founded in 2023 by executives from HubSpot, Google, and Stripe, Maven AGI began by transforming customer service with autonomous agents capable of resolving up to 93% of inquiries. Today, organizations use Maven to bridge silos across support, sales, and operations—replacing broken handoffs with dynamic, context-aware workflows.

Maven AGI is backed by Dell Technologies Capital (DTC), Cisco Investments, SE Ventures (the venture capital firm backed by Schneider Electric), Lux Capital, M13, and E14 Fund. The company is also supported by advisors from OpenAI and Google.

SOURCE Maven AGI

Investment fuels expansion across basketball and volleyball markets with funding from Sapphire Sport, Hyperplane, and new partners including Mighty Capital and Sony Innovation Fund

BOSTON, June 18, 2025 — SportsVisio, putting the power of advanced AI technology into the hands of every athlete, coach, and fan, today announced $3.2 million incremental funding, bringing its total capital raised to $9M. The round includes continued support from existing investors Sapphire Sport, Hyperplane and Sovereign’s Capital, and welcomes Mighty Capital, Sony Innovation Fund, Alumni Ventures, Waterstone Impact Fund and new strategic angels.

The addition of Sony Innovation Fund is of particular importance. With their deep expertise at the intersection of content, entertainment, and emerging technology, Sony Innovation Fund brings a unique perspective that aligns with SportsVisio’s vision to reimagine how sports are captured, analyzed, and shared.

“At Sony Innovation Fund, we invest in technologies with the potential to reshape industries — and SportsVisio is a perfect example of that,” said Austin Noronha, Managing Director, Sony Ventures in the U.S. “Their AI-driven platform delivers professional-grade tools to youth and amateur athletes, transforming how sports moments are captured and shared. We’re excited to back a team that’s expanding access to high-quality sports content and empowering the next generation of athletes.”

“At Mighty Capital, we invest in products that people love — and SportsVisio is a perfect example. They’ve combined cutting-edge AI with an intuitive user experience to create a product that athletes, coaches, and leagues rely on. Their rapid adoption and deep engagement are clear signals of long-term value, and we’re thrilled to partner with them as they transform how sports are experienced and shared,” shared Jennifer Vancini, General Partner at Mighty Capital.

This funding will power sales and marketing growth initiatives, as SportsVisio scales its offerings across basketball and volleyball and new sports like baseball for amateur, youth and professional sports organizations around the world.

“We’re thrilled to have the continued backing of Sapphire Sport and Hyperplane, and to bring on these new partners,” said Jason Syversen, SportsVisio Founder and CEO. “This funding and strategic guidance will help us to expand on our mission to provide smarter, AI-driven solutions that help teams and players win—on and off the court.”

The announcement follows three major product milestones recently achieved: the launch of SportsVisio’s Coach Mode, designed to deliver deeper insights into player performance, team trends, and game flow for the coaching audience; the release of its fully featured volleyball platform, now providing AI-powered stats and automated highlights to one of the fastest-growing sports globally; and the addition of a 3×3 product to enable the fast growing and fast paced format. These innovations reinforce SportsVisio’s commitment to building sport-specific tools that empower coaches and players with actionable data and access to video.

SportsVisio is trusted by more than 150 leagues, clubs, and teams and 16,000 users throughout 16 countries, empowering coaches, athletes, and teams to elevate their game through data-driven decision-making and video highlights and content.

About SportsVisio

SportsVisio is revolutionizing sports analytics through its AI-powered platform that delivers real-time stats, video highlights, and performance insights. The platform supports basketball and volleyball, with plans to expand into additional sports. For more information, find SportsVisio online at www.sportsvisio.com or on social media at facebook.com/SportsVisioAI, instagram.com/sportsvisio/, tiktok.com/@sportsvisio, and linkedin.com/company/sportsvisio.

About Mighty Capital

Mighty Capital is an early-stage venture capital firm that capitalizes on the growing influence of product management in corporate success. Founded by SC Moatti, a former Facebook mobile tech expert, and Jennifer Vancini, a seasoned professional with over 20 years in tech investments and M&A, the firm taps into Moatti’s Products That Count network of over 600,000 product managers and CPOs to gain insights into startups and corporate needs. The real “Why now?” is the AI revolution, which has reshaped corporate power structures, accelerating the shift towards digital products and services, thereby elevating the role of product managers. As a result, Fortune 1000 companies with CPOs have increased 10x in 3 years and are outperforming their peers. Mighty Capital’s focus on this product management revolution has led to high returns and minimized risk. Notable investments include Amplitude, Groq, and Canela. Founders and institutional investors praise the firm for its exceptional value, rapid execution, and ability to spot trends early. Learn more at Mighty.Capital.

About Sony Ventures Corporation

Sony Ventures Corporation manages the Sony Innovation Fund (SIF), which invests in all stages of emerging technology companies, as well as in startups solving global environmental challenges. SIF engages with pioneering startups to help fuel the development of disruptive technologies, launch new businesses, and contribute to the environment while seeking return on investment. Sony Ventures Corporation is headquartered in Japan. Learn more at www.sonyinnovationfund.com.

About Waterstone Impact Fund

WaterStone Impact Fund is a venture capital fund dedicated to accelerating world-class companies that fuel and amplify faith, hope, and love. Targeting companies that utilize AI and robotics, the WaterStone Impact Fund seeks to support ventures that align with its mission of integrating faith-based values with technological innovation. The majority of the fund’s carried interest is directed to the Tim Tebow Foundation, supporting initiatives against human trafficking, child exploitation, orphan care, profound medical needs, and special needs ministry in over 100 countries worldwide. Learn more at waterstoneimpactfund.com.

About Alumni Ventures

Alumni Ventures is America’s largest venture capital firm for individual investors. The firm has raised over $1.4 billion from a community of more than 11,000 accredited investors and built a diversified portfolio of 1,600+ current and historical companies across sectors and stages. Alumni Ventures offers individuals unique access to professionally managed venture capital and backs innovative founders building the future. Learn more at www.av.vc.

SOURCE SportsVisio

Funding to Fuel Expansion of Mealogic’s Meal Delivery Platform, Helping Companies Launch Prepared Meal Delivery Programs that Drive Positive Health Outcomes and New Revenue Streams

WASHINGTON, June 18, 2025 — Mealogic, a leading ready-to-eat B2B2C meal delivery platform that enables companies of all types – including healthcare providers, wellness brands, and clinical programs – to unlock new revenue streams and deliver curated meals that meet specific nutritional standards, today announced that it has secured $16 million in funding to support the company’s rapid growth. The capital will enable Mealogic to deepen its end-to-end customer experience, scale business development, and expand access to convenient, high-quality, personalized nutrition solutions that support both the prevention and reversal of diet-related disease.

Mealogic attracted support from mission-aligned investors committed to improving health through food, including S2G Investments (lead investor), a multi-stage firm with a dedicated food and agriculture strategy, Dohmen Company Foundation, whose vision is life without diet-related disease, U.S. Venture Partners, and Unilever Ventures. Backed by this new investment, Mealogic is uniquely positioned to strengthen and expand the Food as Medicine market by further enabling both emerging and established organizations to deliver nutritious meals tailored to specific dietary standards.

“With strong investor backing and a bold vision, we’re entering a new chapter,” said Ryan Shadrick Wilson, Mealogic’s Executive Chairperson, “Launching a high-quality meal delivery program is hard, but Mealogic makes it easy. And now with a new leader and new capital, the company is ready for meaningful scale.”

“Mealogic is designed to be the engine behind today’s leading Food as Medicine companies,” said Derek Mansfield, CEO of Mealogic. “Our platform allows partners to deliver high-quality meals that reflect their unique dietary programs – whether they’re focused on metabolic health, complementing GLP-1 protocols, or any myriad of other nutrition-focused plans. We handle everything from e-commerce to food production to delivery, which frees up our partners to focus on growth, innovation, and the communities they serve. With more than 40 clients and over 25 science-backed dietary protocols, Mealogic is helping advance both prevention and treatment for diet-related health challenges.”

Unlike direct-to-consumer meal services, Mealogic operates as a white-label platform, enabling healthcare providers, wellness brands, and clinical programs to deliver curated meals that meet specific nutritional standards – such as low sodium, plant-based, or anti-inflammatory – under their own brand. Using a catalog of more than 5,000 nutritionally profiled meals, Mealogic’s system filters options based on each partner’s dietary requirements and handles everything from menu development and payment processing to production, delivery, and customer service.

Mealogic partners with a diverse network of producers across the country to ensure meals are not only health-supportive, but also fresh, locally sourced, culturally authentic, and rich in variety. Each week, the company offers more than 200 unique science-backed dishes designed to support positive health outcomes. With its seamless integration and turnkey model, Mealogic makes it easier for both emerging and established players to enter and scale within the Food as Medicine and healthy prepared meals market.

“Mealogic sits at the convergence of two of the most critical systems we believe we need to transform: food and health,” said Dan Ripma, Vice President at S2G Investments. “At a time when chronic conditions are surging and healthcare costs continue to climb, Mealogic offers providers a scalable, effective way to drive better outcomes through food. Many of our brand partners have shared that the platform has helped them reach new audiences and unlock additional revenue. In our view, it’s exactly the kind of solution needed to address today’s urgent health challenges and build a more sustainable, equitable food system.”

“The Dohmen Company Foundation is committed to strengthening the Food as Medicine ecosystem by supporting organizations like Mealogic that make it easier for providers and entrepreneurs to enter, grow, and thrive in this critical space,” said Rachel Roller, President and CEO of the Dohmen Company Foundation. “From startups to national healthcare systems, Mealogic offers the infrastructure needed to bring nutrition-forward meal programs to life. That kind of enablement is exactly what our country needs right now – a vibrant, expanding market of efficacious food-based health solutions that can reach more people, more effectively.”

The funding comes as Mealogic welcomes new leadership. Mansfield, who stepped into the CEO role earlier this year, brings a vision focused on impact, scalability, and strategic partnerships.

“We envision a future where food-based care is seamlessly integrated into everyday health, and we’re building the infrastructure to make that future possible,” said Mansfield.

About Mealogic:
For businesses looking to expand their impact and revenue through personalized nutrition, Mealogic offers a seamless solution. Mealogic empowers businesses to deliver chef-crafted, nutrition-led meals serving over 25 specialty dietary protocols. Our turnkey platform combines an end-to-end ecommerce experience, a diverse national chef network, and best-in-class delivery services. Transform your community’s nutrition journey with us. Get started at Mealogic.com.

About S2G Investments:
S2G is a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans, and energy. The firm provides capital and value-added resources to companies and leadership teams pursuing market-based solutions designed to deliver greater value, improved outcomes, and enhanced performance over traditional alternatives. With a commitment to creating long-term, measurable outcomes, S2G structures flexible capital solutions that can range from venture funding through growth equity to debt and infrastructure financing. For more information about S2G, visit s2ginvestments.com or connect with us on LinkedIn.

About Dohmen Company Foundation:
With more than 165 years of healthcare experience, Dohmen has found a way to combine the rigor of business with the heart of philanthropy. After exiting the life science industry in 2018, Dohmen shareholders transformed the multi-generational family-owned business to a private foundation. Today, the Dohmen Company Foundation advances its vision of life without diet-related disease in three powerful ways: via its investment fund focused on accelerating the growth of for-profit social businesses with proven food solutions that improve human health, via traditional grant making dedicated to increasing the impact of charitable organizations aligned with our vision, and through public awareness of the surging rates of diet-related disease that threaten our national wellbeing. For more information, please visit dohmencompanyfoundation.org.

About U.S. Venture Partners:
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades, including: Arkose Labs, Box, Carrot Fertility, Cato Networks, Check Point Software, Guidewire, Happy Returns, HeartFlow, HotelTonight, Human Interest, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Kenna, Medigate, Omada Health, Pluto TV, Standard Bariatrics, ThreatMetrix, Trunk Club, Trusteer, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California. More information can be found at www.usvp.com.

About Unilever Ventures:
Unilever Ventures, the venture and growth capital arm of Unilever, partners with entrepreneurs with ground-breaking ideas and ambitions to transform the world. Our mission extends beyond mere capital provision; we enable these visionaries to cultivate distinctive brands and innovative technology solutions that resonate on a global scale. Our investment focuses on both early-stage and growth opportunities that lie at the crossroads of consumer goods, commerce, and technology, primarily in North America, Europe, and Asia. For further information, please visit www.unileverventures.com.

SOURCE Mealogic Inc

LOS ANGELES, June 18, 2025 — All In Food announced its debut with the launch of its Madagascar Vanilla snack bar in retail stores across the U.S. The brand unveiled its name, mission, and look, marking a significant evolution in its impact model and consumer focus. The launch is backed by a $4 million funding round led by Obvious Ventures, fueling the company’s next stage of growth.

Initially co-founded by actress Kristen Bell as This Bar Saves Lives, the brand was acquired in 2022 by GOOD Worldwide, a social impact company that also owns media brand Upworthy. Now introduced as All In, the company enters the market with a renewed focus on crafting delicious, organic snacks, anchored by a mission to nourish communities and drive meaningful change.

“We are making bars that are absolutely craveable, and every bite brings something extra,” said James McGinnis, CEO of All In and longtime CPG leader. “We’re All In on ingredients that matter, business that gives back, and community-first action that starts close to home.”

McGinnis, a seasoned CPG executive, brings senior leadership experience from Clif Bar, Qualitas Health, and Indigo Wild. He previously held roles at major food and personal care companies, including Dial and Pinnacle Foods. Under his leadership, All In is growing its national retail footprint marking a significant milestone for the brand.

All In’s launch includes five snack bar flavors, all certified USDA Organic, non-GMO, gluten-free, and palm oil free. Their kids-focused line is free from the top eight allergens and is safe for schools as it is produced in a dedicated nut-free facility.

The $4 million in new capital, led by Obvious Ventures, will support retail expansion, team growth, and ongoing R&D. “All In is exactly the kind of brand we look to back—one that delivers real impact without compromising quality or joy,” said James Joaquin, Co-Founder and Managing Director at Obvious Ventures.

All In is showing up where it counts—with snacks that taste amazing and a mission to give back,” said Max Schorr, CEO of GOOD Worldwide and All In board member. “All in represents a deepened commitment to what matters: great food, strong values, and community-first action. We’re delighted to launch the brand with Obvious Ventures and Kristen Bell and are energized for what’s ahead.”

You can learn more at https://allinfood.com/ or follow @AlInFood on Instagram. 

ABOUT ALL IN FOOD
All In makes organic, craveable snacks that support food access in communities across the U.S. Every purchase helps fund grassroots organizations working to create a healthier, more equitable food system. Originally co-founded by Kristen Bell and a team of changemakers, All In is reimagining what a snack company can do.

Press Contact
Kathy Osborne
[email protected]

SOURCE All In Food

New Inference-First Data Infrastructure Overcomes Pilot Paralysis Impacting the Majority of AI Initiatives; Frees Data and AI Teams to Focus on Innovation and Competitive Advantage vs. Managing Complex Infrastructure

SAN MATEO, Calif., June 18, 2025 — Typedef Inc., turning AI prototypes into scalable, production-ready workloads that generate immediate business value, today has come out of stealth mode with $5.5 million in seed funding led by early stage investors Pear VC with participation from Verissimo Ventures, Monochrome Ventures, Tokyo Black, and several angel investors.

The Artificial Intelligence (AI) infrastructure market is projected to reach $200 billion by 2028. With a new purpose-built AI data infrastructure for modern workloads, Typedef is helping AI and data teams overcome the well-documented epidemic affecting the bulk of enterprise AI projects – failure to scale. 

“It is extremely difficult to put AI workloads into production in a predictable, deterministic and operational way, causing most AI projects to linger in the prototype phase – failing to achieve business value or demonstrate ROI,” said Yoni Michael, Co-founder of Typedef. “The fact is, legacy data platforms weren’t built to handle LLMs, inference, or unstructured data. As a result, the workaround has been a patchwork of systems, aging technologies and tooling, or DIY frameworks and data-processing pipelines that are brittle, unreliable, and don’t scale. Typedef is righting these wrongs with a solution built from the ground up with features to build, deploy, and scale production-ready AI workflows – deterministic workloads on top of non-deterministic LLMs.”

Typedef makes it easy to run scalable LLM-powered pipelines for semantic analysis with minimal operational overhead. The developer-friendly solution manages all the complex properties of mixed AI workloads like token limits, context windows, and chunking through a clean, composable interface with the APIs and relational models engineers recognize. Typedef allows for rapid, iterative prompt and pipeline experimentation to quickly determine production-ready workloads that will demonstrate value – then realize that potential at scale.

“Data complexities and flawed data inputs are common obstacles on the journey to AI-readiness,” said Kostas Pardalis, Co-founder of Typedef. “AI and data teams want the same rigor and reliability they expect from traditional data pipelines. They want to supercharge their online analytic processing (OLAP) workloads with AI, extract new value from proprietary data, and run complicated agentic workloads with predictability and scalability. Typedef is making this possible, allowing teams to finally deliver on their AI promises to stakeholders.”

Typedef is completely serverless bypassing any infrastructure provisioning or configuration. Users simply download the open-source client library, connect their data sources and start building their AI or agentic pipelines with just a few lines of code. No complex setup, no infrastructure to provision, no brittle custom integrations to troubleshoot.

“Typedef lets us build and deploy semantic extraction pipelines across thousands of policies and transcripts in days not months,” said Lee Maliniak, Chief Product Officer at Matic, a leading insurance-tech platform that partners with top-rated carriers. “We’ve dramatically reduced the time it takes to eliminate errors caused by human analysis, significantly cut costs, and lowered our Errors and Omissions (E&O) risk.”

“Typedef is ushering in the new era of AI infrastructure where model training has given way to inference and where teams can build reliable, scalable, and cost-effective Large Language Model (LLM) workloads without the complexity or strain of managing infrastructure,” said Arash Afrakhteh, Partner at Pear VC. “I’ve backed this team because they’ve lived the problem, know what’s needed, and have the added experience of running data infrastructure startups to successful exits.”

About Typedef Inc.
Typedef enables organizations to drive new levels of analytic insight and competitive advantage from AI initiatives – moving AI projects from pilot to production faster, more efficiently, and at scale. The purpose-built, AI data infrastructure for modern workloads handles LLM-powered pipelines, unstructured data processing, inference complexity, and the running of batch AI workloads in production, allowing data and AI teams to focus less on managing complex infrastructure and more on driving innovation and business value – fully realizing the promise of AI. To learn more about Typedef or to demo the product, visit www.typedef.ai

Media Contact
April H. Burghardt
PR Consultant
[email protected]
646-246-0484

SOURCE Typedef

BRNO, Czech Republic, June 18, 2025 — The European Union’s vision of digital sovereignty enters a new phase with the launch of DNS4EU, a public DNS resolver providing secure, privacy-focused, and reliable internet access to EU citizens. The service is led by Whalebone, a cybersecurity company born in the Brno region, one of Europe’s most dynamic hubs for digital innovation and cyber resilience.

Developed within a European consortium with support from ENISA and national CERTs, DNS4EU is now fully operational and available to the public. It is the first EU-backed resolver offering a secure, transparent, privacy-first alternative to services like Google and Cloudflare.

DNS4EU includes several components: a public resolver; DNS4GOV, a commercial-grade service for governments and critical infrastructure; and a threat intelligence exchange network supporting secure DNS adoption and cross-border cybersecurity coordination.

“After years of building a global market leader position in large scale on-prem/hybrid deployments of protective DNS, we decided to step up and challenge Cloudflare and Google in the public resolver space. More privacy, more transparency and more dedication,” said Richard Malovič, CEO of Whalebone.

The launch highlights the Czech Republic’s growing role in Europe’s cybersecurity. With the center in Brno, the region is home to an active community of cybersecurity companies and a collaborative environment with global impact. Key institutions like Masaryk University and Brno University of Technology lead major European cybersecurity projects — QARC and CCAT — underscoring the region’s expertise in quantum-safe cryptography and certification. Both universities are also founding members of the CyberSecurityHub^CZ, a national competence center fostering collaboration across sectors.

According to a recent JIC report, cybersecurity is the region’s most dynamic tech sector by venture capital investment. In early 2025 alone, local companies secured almost €40 million — including rounds raised by Whalebone, Threatmark, and Safetica. This builds on Brno’s strong record of cybersecurity ventures that became international players, including the $28.4 million acquisition of Runecast and the sale of Flowmon Networks. The city also gave rise to AVG Technologies, the Czech Republic’s first unicorn, acquired by Avast in 2016 and now operating globally as Gen.

“Brno’s cybersecurity success is built on deep research, strong talent, and strategic support for startups,” said Petr Chládek, CEO, JIC innovation agency. “DNS4EU proves the region can deliver digital sovereignty at a European scale.”

-DNS4EU se pone en marcha, lo que confirma la solidez del ecosistema de ciberseguridad de Brno, según la agencia de innovación JIC

BRNO, República Checa, 18 de junio de 2025 — La visión de la Unión Europea sobre la soberanía digital entra en una nueva fase con el lanzamiento de DNS4EU, un solucionador de DNS público que proporciona acceso a internet seguro, centrado en la privacidad y fiable a los ciudadanos de la UE. El servicio está liderado por Whalebone, una empresa de ciberseguridad nacida en la región de Brno, uno de los centros más dinámicos de Europa en innovación digital y ciberresiliencia.

Desarrollado en el marco de un consorcio europeo con el apoyo de ENISA y los CERT nacionales, DNS4EU ya está plenamente operativo y disponible para el público. Es el primer solucionador respaldado por la UE que ofrece una alternativa segura, transparente y que prioriza la privacidad a servicios como Google y Cloudflare.

DNS4EU incluye varios componentes: un solucionador público; DNS4GOV, un servicio de nivel comercial para gobiernos e infraestructuras críticas; y una red de intercambio de inteligencia sobre amenazas que apoya la adopción de un DNS seguro y la coordinación transfronteriza en materia de ciberseguridad.

“Tras años de consolidar nuestra posición de liderazgo global en implementaciones locales/híbridas a gran escala de DNS protector, decidimos dar un paso al frente y desafiar a Cloudflare y Google en el ámbito de los resolutores públicos. Más privacidad, más transparencia y más dedicación,” dijo Richard Malovič, consejero delegado de Whalebone.

El lanzamiento destaca el creciente papel de la República Checa en la ciberseguridad de Europa. Con el centro en Brno, la región alberga una comunidad activa de empresas de ciberseguridad y un entorno colaborativo con impacto global. Instituciones clave como la Universidad Masaryk y la Universidad de Tecnología de Brno lideran importantes proyectos europeos de ciberseguridad (QARC y CCAT), lo que subraya la experiencia de la región en criptografía y certificación de seguridad cuántica. Ambas universidades también son miembros fundadores de CyberSecurityHub^CZ, un centro nacional de competencia que fomenta la colaboración intersectorial.

Según un reciente informe de JIC, la ciberseguridad es el sector tecnológico más dinámico de la región en términos de inversión de capital de riesgo. Tan solo a principios de 2025, empresas locales obtuvieron casi 40 millones de euros, incluyendo rondas de financiación de Whalebone, Threatmark y Safetica. Esto se suma al sólido historial de Brno en empresas de ciberseguridad que se han convertido en actores internacionales, incluyendo la adquisición de Runecast por 28,4 millones de dólares y la venta de Flowmon Networks. La ciudad también fue cuna de AVG Technologies, el primer unicornio de la República Checa, adquirido por Avast en 2016 y que ahora opera globalmente como Gen.

“El éxito de Brno en ciberseguridad se basa en una investigación exhaustiva, un talento excepcional y el apoyo estratégico a las empresas emergentes”, afirmó Petr Chládek, consejero delegado de la agencia de innovación JIC. “DNS4EU demuestra que la región puede lograr la soberanía digital a escala europea”.

Funding now totals over $43 million, strengthened leadership focused on a 2026 commercial launch of the OncoIntelligence™-driven, PreciseBreast™

NEW YORK, June 18, 2025 — PreciseDx, the leading innovator behind PreciseBreast, a novel breast cancer diagnostic that is powered by OncoIntelligence, their proprietary AI-platform, today announced the successful closing of $11 million in funding and two key leadership hires. This latest round of funding was led by Eventide Asset Management (“Eventide”), Merck Global Health Innovation Fund and Philips Ventures and included Labcorp, Quest Diagnostics, GenHenn Capital Venture, along with other existing investors. This funding will help prioritize the company’s ongoing clinical data collection, commercial expansion and planning for the 2026 launch of its flagship product, PreciseBreast.

The news also comes as the company announces two critical leadership appointments. Eric Converse, a seasoned leader with imaging diagnostics and AI/ML technologies experience has assumed the role of Chief Executive Officer. Additionally, Ed Sitar, who has over 30 years of financial leadership in diagnostics and market access, has become the Chief Financial Officer.

“This represents a defining moment for PreciseDx and our mission to support physicians and patients in making more informed, biologically driven decisions in the management of breast cancer,” said Founder Carlos Cordon-Cardo, MD, PhD, Professor and System Chair of Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai. “With PreciseBreast, we are introducing the first-of-its-kind AI-enabled diagnostic tool grounded in the underlying biology of tumor progression, leading in the new era of diagnostic precision. This gets us one step closer to achieving our vision and shifting the paradigm for evaluating risk of tumor recurrence with the ultimate goal of predicting treatment benefit. We are proud to be advancing a technology that empowers both pathologists and oncologists, and most importantly, offers hope to patients and their families facing breast cancer.”

PreciseBreast is designed specifically to speed the process of care planning for breast cancer patients. The test provides comprehensive insight into phenotype and grade to accurately predict the risk of recurrence within hours. PreciseBreast uses OncoIntelligence, its proprietary AI-platform, to combine seven morphologic features with four clinical factors to produce a single OncoIntelligence Score between 0 and 100. PreciseBreast has been clinically validated by prominent research institutions and in more than 3,000 breast cancer cases, for its ability to accurately and reliably stratify patients into two cohorts based on risk of disease recurrence at six years.

“This latest round of funding reflects strong investor confidence in PreciseBreast, enabling us to expand access to OncoIntelligence, our AI platform that has the potential to improve outcomes and save lives of patients affected by breast cancer,” said Eric Converse, CEO. “With early success in PreciseBreast, OncoIntelligence can begin to provide treatment guidance for many other solid tumor types.”

For more information on PreciseBreast and PreciseDx, please visit precisedx.ai.

Contact: 
[email protected] 

*Both Mount Sinai and Carlos Cordon-Cardo have a financial interest in PreciseDx. Either or both could potentially benefit financially from statements regarding PreciseDx.

SOURCE PreciseDx

Des investisseurs existants apportent des fonds pour terminer l’essai international RESPONDER-HF

TEWKSBURY, Mass., 17 juin 2025 — Corvia Medical, Inc, une société qui se consacre à la transformation du traitement de l’insuffisance cardiaque, a annoncé aujourd’hui la clôture d’un cycle de financement de 55 millions de dollars auprès du syndicat d’investissement existant de la société, composé de Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, et de deux investisseurs stratégiques.

Les fonds seront utilisés pour compléter l’étude RESPONDER-HF en cours, une étude de confirmation en double aveugle, randomisée, contrôlée par simulacre, de la Corvia^® Atrial Shunt, actuellement en cours dans plus de 65 institutions sur trois continents. L’étude devrait produire les données cliniques finales nécessaires à l’approbation par la FDA de la dérivation en tant que traitement innovant de l’insuffisance cardiaque avec fraction d’éjection préservée et légèrement réduite (HFpEF/HFmrEF).

“Nous sommes profondément reconnaissants du soutien inébranlable de nos investisseurs de longue date alors que nous avançons vers la soumission à la FDA de la Corvia Atrial Shunt”, a déclaré George Fazio, PDG de Corvia Medical. Leur engagement va dans le sens de notre mission, qui est de mettre ce traitement transformateur de l’insuffisance cardiaque à la disposition de millions de patients dans le monde entier.

Paul LaViolette, président du conseil d’administration de Corvia Medical, a ajouté : ” Nous sommes fermement convaincus que Corvia a le potentiel de modifier fondamentalement le paysage du traitement de l’insuffisance cardiaque, et nos investisseurs partagent cette vision. Grâce à ces ressources, nous sommes bien équipés pour mener la société à travers le processus d’approbation et introduire cette thérapie révolutionnaire sur le marché”.

À propos de l’insuffisance cardiaque (IC) et de la Corvia Atrial Shunt

Plus de 26 millions de personnes dans le monde sont atteintes d’hypertension, et la majorité d’entre elles souffrent d’hypertension artérielle, ce qui en fait le plus grand besoin clinique non satisfait dans le domaine de la médecine cardiovasculaire. Le Corvia Atrial Shunt est conçu pour réduire la pression auriculaire gauche élevée, principal facteur des symptômes de l’insuffisance cardiaque, en créant un passage entre les oreillettes gauche et droite, réduisant ainsi les événements d’insuffisance cardiaque et améliorant la qualité de vie. La FDA a accordé à la Corvia Atrial Shunt le statut de Breakthrough Device en 2019. Pour plus d’informations sur l’éligibilité à l’étude RESPONDER-HF, veuillez consulter le site https://treatmyheartfailure.com.

À propos de Corvia Medical, Inc.

Corvia Medical, Inc. révolutionne le traitement de l’insuffisance cardiaque grâce à de nouveaux dispositifs cardiovasculaires transcathéter. Fondée en 2009 et basée à Tewksbury, MA, la société privée Corvia a pour objectif de transformer la norme de soins pour le traitement de l’insuffisance cardiaque, permettant ainsi aux patients de reprendre leur vie en main. Visitez le site https://corviamedical.com.

CONTACT AVEC LES MÉDIAS :
Lisa Ensz
+1 978-654-6120
[email protected]